Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial
2021 · The Lancet Haematology · 61 citations
https://doi.org/10.1016/s2352-3026(21)00333-1
K
Kazunori Murai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
126
Papers
1.2K
Citations
16
h-index
26
i10-index
Kazunori Murai is an academic researcher from Sapporo University. The author has contributed to research in topics: Chronic Myeloid Leukemia Treatments & Chronic Lymphocytic Leukemia Research & Platelet Disorders and Treatments. The author has an h-index of 16, co-authored 108 publications.
ORCID: 0000-0002-7353-3495Papers by this author
worksKIR3DL1-HLA-Bw status in CML is associated with achievement of TFR: the POKSTIC trial, a multicenter observational study
2024 · Blood Neoplasia · 7 citations
https://doi.org/10.1016/j.bneo.2024.100001
Cardiac Malignant Lymphoma with Diffuse Extension to the Left Ventricle
2024 · Internal Medicine · 0 citations
https://doi.org/10.2169/internalmedicine.3943-24
Multiple Organ Failure Due to Leukostasis Caused by Rapidly Progressive Hyperleukocytosis: A Case Report
2025 · Cureus · 0 citations
https://doi.org/10.7759/cureus.88871
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat